Information in Your Fingertips: Optimizing Vascular Health with PAT technology

Itamar Medical News Journal

Subscribe to Itamar Medical News Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Itamar Medical News Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

Top Stories

Answers Corporation (NASDAQ: ANSW), creators of the leading answer engine offering™ and™, announced today a unique cooperation with the specialists at Itamar Medical, a world leading developer of cardiac diagnostic equipment, who will spearhead the supervision of the new Cardiovascular Health category on WikiAnswers is Answers Corp’s Social Knowledge Q&A site recently ranked by comScore as the #1 fastest growing domain of the top 1,500 in the US in 2007. In an effort to facilitate the process whereby patients receive the most up-to-date information, Answers Corp. and Itamar Medical will use the WikiAnswers Social Knowledge community platform for facilitating more efficient dialogue between doctors and patients. The companies will leverage the power of the Internet as a global knowledge repository where user-generated con... (more)

Attunity Introduces ODR Solutions for Oracle Customers

Attunity Ltd., introduces today a set of solutions based on a new concept coined 'Operational Data Replication' (ODR), which is designed to enable the large market of Oracle customers to replicate data in real-time to and from Oracle databases, at an affordable price point. Today more than ever, using real-time information in business intelligence and operations is believed to be crucial in order to compete effectively and set organizations apart in their ability to serve customers, optimize operations, and as a result - improve margins. In many cases, doing so requires replicating operational data, and making up-to-the-minute information accessible for employees, customers, and partners. According to Gartner, "Business analysts and architects should study business processes to determine where monitoring and near-real-time reporting of key performance indicators wou... (more)

Flavonoids Can Prevent Impairment of Endothelial Function After High-Fat Meals

In the results of a new clinical study published by the Oxford Journal of Evidence-Based Complementary and Alternative Medicine, researchers find that supplementing your diet with flavonoids can reduce the acute decline in endothelial function caused by eating a high-fat meal. The endothelium is the inner lining of blood vessels that allows blood to flow smoothly, and endothelial dysfunction is the hardening of these vessels that leads directly to heart attacks, strokes, and other fatal hypertension diseases. Various foods high in flavonoids such as black tea, dark chocolate, red wine and citrus fruits have been associated with a lowered risk for cardiovascular disease, and this new study by the Carolinas HealthCare System helps identify endothelial function as a key link between flavonoid supplementation and the prevention of heart disease. In the study, Itamar Medi... (more)

Attunity Partners with Open Text

CMS Journal on Ulitzer Attunity Ltd. announced today that it has partnered with Open Text Corporation, an enterprise software company and a leader in enterprise content management, who will market advanced data connectivity solutions, including legacy decommissioning, data lifecycle management and real-time data warehousing, which will leverage Attunity's legacy data connectivity and low-impact change data capture (CDC) technology. "We are excited to partner with Open Text to promote solutions that maximize return on investment and deliver data in real time," said Mel Passarelli, VP Sales and Operations at Attunity. "By combining two 'best-of-breed' solutions, this strategic relationship will provide a cost-effective, real-time data integration solution that enables organizations to have the right information available at the right time, which we believe, is key to ... (more)

Prominent Hedge Fund Adopts Attunity's Change Data Capture (CDC) for SSIS Solution to Enable Trading and Reporting in Real Time

BURLINGTON, Massachusetts, October 1 /PRNewswire-FirstCall/ -- Attunity Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration and event capture software, announced today that a prominent, privately-held hedge fund firm based in the US has selected Attunity's Change Data Capture (CDC) for SSIS solution to enable access to the hedge fund's trading and reporting databases in real time, streamline their business and improve operations and business intelligence (BI). According to the hedge fund firm, Attunity's non-intrusive CDC technology enabled it to quadruple their standard trade volume and extended $10 million in additional business opportunity. Having access to the most current data possible in real-time is a business imperative for hedge funds and others in the financial services industry. Change Data Capture (CDC) technology monitors and tran... (more)

Itamar Medical's Endo-PAT2000 Now Available in Italy

Caesarea, Israel - Itamar Medical, an international medical technology company developing  noninvasive diagnostic systems using the Peripheral Arterial Tone (PAT™) Signal, announced its distribution agreement with EndoTech SPA to bring Itamar Medical's patented Endo-PAT2000,  the first simple, office-based diagnostic test for the assessment of endothelial function, to the Italian market. EndoTech SPA, based in Como, Italy, specializes in the distribution and launch of innovative medical instrumentation technologies in Italy, and features extensive knowledge and experience in the cardiovascular field. This ideal partnership will allow Itamar Medical to reach new market and distribution goals for the Endo-PAT2000.  With powerful sales force that reaches every corner of the Italian market, EndoTech SPA offers the optimized customer, scientific, and technical support fo... (more)

Attunity Extends its Partnership with Microsoft to Enable Heterogeneous Change Data Capture

Microsoft Developer on Ulitzer Attunity Ltd., a provider of real-time data integration and event capture software, announced today a strategic partnership to market solutions that enable real-time business intelligence and efficient data integration based on the companies' data integration products. The solution, based on Microsoft's SQL Server Integration Services (SSIS) and Attunity's low-impact change data capture (CDC) technology, enables efficient and real-time integration of heterogeneous data with significant cost savings. Enabling real-time business intelligence and guaranteeing consistency of business information across heterogeneous data silos are challenges facing many organizations looking to improve customer service, optimize operations, and increase margins. Delivering on these capabilities in a cost-effective way has become more and more challenging a... (more)

Helping New Yorkers Prevent Heart Attacks: Itamar Medical Joins The Fight With New Campaign

NEW YORK, Nov. 8, 2013 /PRNewswire/ -- In response to the disturbing fact that people are more likely to die of a heart attack in New York City than anywhere else in the U.S., medical device company Itamar Medical (TASE: ITMR), today announced the launch of its first-ever initiative in the U.S. to increase awareness of endothelial (arterial) function testing and the importance of early detection in preventing heart attacks, particularly for symptomatic patients. The New York area was selected as the first city to kick off "Don't Ignore Your EndoScore" The campaign rolls out in New York the week of November 11. The campaign will focus on providing information and options to help individuals, families and communities to best maximize their heart health, and will include testing with Itamar's EndoPAT test at participating New York-based hospitals and medical practices... (more)

BioMarin Uses Itamar Medical's Endo-PAT2000 In Successful Phase 2 Study For New Treatment For Sickle Cell Disease

Normal 0 false false false MicrosoftInternetExplorer4 Caesarea, Israel — Itamar Medical, an international medical technology company developing noninvasive diagnostic technology using the Peripheral Arterial Tone (PAT™) Signal, announced the use of the company's patented Endo-PAT2000 in BioMarin Pharmaceutical Inc.'s phase 2 study of patients with Sickle Cell Disease (SCD). The Endo-PAT2000 was used to measure endothelial function in a study designed to evaluate whether the drug 6R-BH4 can improve endothelial function in SCD patients. Using measurements obtained from Endo-PAT tests, BioMarin announced Oct. 15 that the oral administration of 6R-BH4 is associated with an improvement of endothelial function in SCD patients. According to the study's key findings, Endo-PAT measurements showed that patients treated with escalating doses of 6R-BH4 showed improved endothel... (more)

Red Hat Recognizes Student, Itamar Reis Peixoto, for Contributions to Fedora and Open Source Software

Red Hat, Inc. (NYSE: RHT), the world’s leading provider of open source solutions, today announced the Fedora Project, a Red Hat sponsored and community-supported open source collaboration, has named Itamar Reis Peixoto as the recipient of the 2012 Fedora Scholarship. Now in its fifth year, the Fedora Scholarship recognizes college and university-bound students across the globe for their contributions to free software and the Fedora Project. Peixoto was chosen due to his work in various areas of the Fedora Project, including packaging, participating as a Fedora Ambassador, and helping the free-media team promote broader availability of Fedora. Fedora is built by a worldwide community of people, and anyone is able to join and contribute across multiple functions including content writers, designers and marketers to translators, web developers and system administrator... (more)

Actian and Attunity Join Forces to Simplify Real-time Big Data Warehousing

Attunity Replicate for Actian Vectorwise Delivers High-performance Data Replication for Faster Analytics Redwood City, CA and Burlington, MA - October 25, 2012 - Actian Corporation, creators of Vectorwise, the innovative performance analytic database, and Attunity Ltd. (NASDAQ: ATTU), a leading provider of information availability software solutions, announced today they have joined forces to create Attunity Replicate for Actian Vectorwise, a solution that meets the high-performance demands of big data while being significantly simple to use. The solution is designed to provide high-performance, end-to-end data loading with quick time-to-value for Actian Vectorwise environments. The optimized replication solution is immediately available worldwide. Attunity Replicate for Actian Vectorwise empowers enterprise customers to quickly load data from heterogeneous data sou... (more)